Clinical Trial Update: Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing whether maintaining or stopping immunosuppressive therapy is appropriate for patients with ANCA-associated vasculitis and end-s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anca-associated Vasculitis
• End-stage Renal Disease

Drugs mentioned

• Immunosuppressive therapy

Snippet

Sponsor: Centre Hospitalier Departemental Vendee | Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, End Stage Renal Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING